Phenflutermine
| Clinical data | |
|---|---|
| Other names | Phenflutermin; 3-Trifluoromethyl-N-ethyl-α-methylamphetamine; 3-Trifluoromethyl-N-ethylphentermine; N-Ethyl-α,α-dimethyl-3-trifluoromethylphenethylamine; N-Et-α,α-Me-3-TFMPEA; Fenflutermine |
| ATC code |
|
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C13H18F3N |
| Molar mass | 245.289 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Phenflutermine, also known as 3-trifluoromethyl-N-ethyl-α-methylamphetamine or as 3-trifluoromethyl-N-ethylphentermine, is a chemical compound of the phenethylamine, amphetamine, and phentermine families.[1] It is the combined or hybrid derivative of the fenfluramine and phentermine, which were used together in the withdrawn combination anorectic fenfluramine/phentermine (Fen-Phen).[1] The compound was first described in the scientific literature by Daniel Trachsel in his book on phenethylamines in 2013.[1] It is not known to have been synthesized, tested, or otherwise described in the literature.[1] However, both fenfluramine and phentermine are known to act as monoamine releasing agents and to have anorectic effects.[2][3]
See also
[edit]References
[edit]- 1 2 3 4 Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. ISBN 978-3-03788-700-4. OCLC 858805226. Archived from the original on 21 August 2025.
- ↑ Rothman RB, Baumann MH (2000). "Neurochemical mechanisms of phentermine and fenfluramine: Therapeutic and adverse effects". Drug Development Research. 51 (2): 52–65. doi:10.1002/1098-2299(200010)51:2<52::AID-DDR2>3.0.CO;2-H. ISSN 0272-4391.
- ↑ Rothman RB, Baumann MH (2006). "Therapeutic potential of monoamine transporter substrates". Current Topics in Medicinal Chemistry. 6 (17): 1845–1859. doi:10.2174/156802606778249766. PMID 17017961.